# Inflammation and Threat Sensitivity in PTSD

> **NCT03048929** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 30 (actual)

## Conditions studied

- Posttraumatic Stress Disorder

## Interventions

- **BIOLOGICAL:** Typhoid Vi Polysaccharide Vaccine
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03048929
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2020-03-30
- **Final completion:** 2021-03-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03048929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03048929, "Inflammation and Threat Sensitivity in PTSD". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03048929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*